Global Melanoma Therapeutics Market Size Worth Over 4.63 Billion by 2 Global Melanoma Therapeutics Market Size Worth Ove | Página 3

 Amelanotic melanoma
 Others
By Diagnosis:






Ultrasound
Blood Tests
Dermatoscopy
Sentinel lymph node biopsy
X-rays
CT Scan
By Treatment:


Early melanoma
Advanced melanoma
 Biological therapy
 Targeted therapy
 Surgery
 Chemotherapy
 Radiotherapy
 Immune therapy
The market has also been geographically segmented into North America, Europe, Asia-
Pacific and the Rest of the World. North America accounted for the largest share in the
global Melanoma Therapeutics due to the increasing frequency of melanoma cases and
technological advancements in this region. However, The Asia-Pacific region, which consists
of countries such as China and India is projected to grow substantially due to the large
population base and rising prevalence of melanoma in these countries. For more of regional
analysis check out the following reports.





North America Melanoma Therapeutics Market
Europe Melanoma Therapeutics Market
Asia-Pacific Melanoma Therapeutics Market
Latin America Melanoma Therapeutics Market
Middle East and Africa Melanoma Therapeutics Market
The major companies dominating the Melanoma Therapeutics market are Bristol-Myers
Squibb Co., Merck and Co., F. Hoffmann-La Roche, Amgen Inc., Celgene Corp, Daiichi
Sankyo, and Pfizer Inc.
The Melanoma Therapeutics Market study offers the following deliverables:

Global, regional and country-level analysis and forecasts of the study market;
providing Insights on the geographical areas in which this industry is blooming